References
- Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality survival, and risk factors. Prz Gastroenterol. 2019;14(2):89–14. doi: 10.5114/pg.2018.81072
- Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics. CA Cancer J Clin. 2020;70(3):145–164. doi: 10.3322/caac.21601
- Siegel RL, Wagle NS, Cercek A, et al. Colorectal cancer statistics. CA Cancer J Clin. 2023;73(3):233–254. doi: 10.3322/caac.21772
- Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584–590. doi: 10.1097/CM9.0000000000002108
- Yuan ZR, Weng S, Ye C, et al. CSCO guidelines for colorectal cancer version 2022: updates and discussions. Chin J Cancer Res. 2022;34(2):67–70. doi: 10.21147/j.issn.1000-9604.2022.02.01
- Xie YH, Gao Q-Y, Cai G-X, et al. Fecal clostridium symbiosum for noninvasive detection of early and advanced colorectal cancer: test and validation studies. EBioMedicine. 2017;25:32–40. doi: 10.1016/j.ebiom.2017.10.005
- Han S, YANG XI, QI Q, et al. Potential screening and early diagnosis method for cancer: tongue diagnosis. Int J Oncol. 2016;48(6):2257–2264. doi: 10.3892/ijo.2016.3466
- McGovern J, Dolan RD, Horgan PG, et al. The prevalence and prognostic value of frailty screening measures in patients undergoing surgery for colorectal cancer: observations from a systematic review. BMC Geriatr. 2022;22(1):260. doi: 10.1186/s12877-022-02928-5
- Baxter NT, Ruffin M, Rogers MA, et al. Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions. Genome Med. 2016;8(1):37. doi: 10.1186/s13073-016-0290-3
- Dominguez-Bello MG, Godoy-Vitorino F, Knight R, et al. Role of the microbiome in human development. Gut. 2019;68(6):1108–1114. doi: 10.1136/gutjnl-2018-317503
- Feng Q, Liang S, Jia H, et al. Gut microbiome development along the colorectal adenoma–carcinoma sequence. Nat Commun. 2015;6(1):6528. doi: 10.1038/ncomms7528
- Yachida S, Mizutani S, Shiroma H, et al. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat Med. 2019;25(6):968–976. doi: 10.1038/s41591-019-0458-7
- Georg Z, Tap, J., Voigt, A.Y. et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol. 2014;10:1–12.
- Flynn KJ, Baxter NT, Schloss PD, et al. Metabolic and community synergy of oral bacteria in colorectal cancer. mSphere. 2016;1(3):1–6. doi: 10.1128/mSphere.00102-16
- Li Y, Cui J, Liu Y, et al. Oral, tongue-coating microbiota, and metabolic disorders: a novel area of interactive research. Front Cardiovasc Med. 2021;8:730203. doi: 10.3389/fcvm.2021.730203
- Pang W, Zhang D, Zhang J, et al. Tongue features of patients with coronavirus disease 2019: a retrospective cross-sectional study. Integr Med Res. 2020;9(3):100493. doi: 10.1016/j.imr.2020.100493
- Fan ZX, Tang P, Li C, et al. Fusobacterium nucleatum and its associated systemic diseases: epidemiologic studies and possible mechanisms. Journal Of Oral Microbiology. 2022;15(1):1. doi: 10.1080/20002297.2022.2145729
- Rashid MU, Weintraub A, Nord CE. Effect of new antimicrobial agents on the ecological balance of human microflora. Anaerobe. 2012;18(2):249–253. doi: 10.1016/j.anaerobe.2011.11.005
- Brandon P. Tongue: anatomy, function, and common disorders-How this organ helps with eating, tasting, speaking, and breathing. Verywell Health Com/tongue-Anatomy-4774957. 2023;10:03.
- Chen H. The composition of the oral microbiome and its relationship with human diseases master. Shanghai Jiao Tong University. 2016.
- Seerangaiyan K, Juch F, Winkel EG. Tongue coating: its characteristics and role in intra-oral halitosis and general health—a review. J Breath Res. 2018;12(3):034001. doi: 10.1088/1752-7163/aaa3a1
- Schmidt TS, Hayward MR, Coelho LP, et al. Extensive transmission of microbes along the gastrointestinal tract. Elife. 2019;8. doi: 10.7554/eLife.42693
- Zeng X, Gupta RK. Call for papers: emerging markets and technologies. Biopreserv Biobank. 2022;20(1):1–11. doi: 10.1089/bio.0113
- Russo E, Bacci G, Chiellini C, et al. Preliminary comparison of oral and intestinal human microbiota in patients with colorectal cancer: a pilot study. Front Microbiol. 2017;8:2699. doi: 10.3389/fmicb.2017.02699
- Segata N, Waldron L, Ballarini A, et al. Metagenomic microbial community profiling using unique clade-specific marker genes. Nat Methods. 2012;9(8):811–814. doi: 10.1038/nmeth.2066
- Beghini F, McIver LJ, Blanco-Míguez A, et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. Elife. 2021;10. doi: 10.7554/eLife.65088
- Nicola S, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60. doi: 10.1186/gb-2011-12-6-r60
- Dhariwal A, Chong J, Habib S, et al. MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data. Nucleic Acids Res. 2017;45(W1):W180–W188. doi: 10.1093/nar/gkx295
- Mallick H, Rahnavard A, McIver LJ, et al. Multivariable association discovery in population-scale meta-omics studies. PLOS Comput Biol. 2021;17(11):e1009442. doi: 10.1371/journal.pcbi.1009442
- Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature. 2011;473(7346):174–180. doi: 10.1038/nature09944
- Lu H, Ren Z, Li A, et al. Deep sequencing reveals microbiota dysbiosis of tongue coat in patients with liver carcinoma. Sci Rep. 2016;6(1):33142. doi: 10.1038/srep33142
- Hu J, Han S, Chen Y, et al. Variations of tongue coating microbiota in patients with gastric cancer. BioMed Res Int. 2015;2015:1–7. doi: 10.1155/2015/173729
- Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14(2):207–215. doi: 10.1016/j.chom.2013.07.007
- Castellarin M, Warren RL, Freeman JD, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22(2):299–306. doi: 10.1101/gr.126516.111
- LaCourse KD, Zepeda-Rivera M, Kempchinsky AG, et al. The cancer chemotherapeutic 5-fluorouracil is a potent Fusobacterium nucleatum inhibitor and its activity is modified by intratumoral microbiota. Cell Rep. 2022;41(7):111625. doi: 10.1016/j.celrep.2022.111625
- Galeano Nino JL, Wu H, LaCourse KD, et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature. 2022;611(7937):810–817. doi: 10.1038/s41586-022-05435-0
- Zhang S, Kong C, Yang Y, et al. Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer. Theranostics. 2020;10(25):11595–11606. doi: 10.7150/thno.49515
- Jeong JK, Ahn K, Mun S, et al. Understanding the bacterial compositional network associations between oral and gut microbiome within healthy Koreans. J Oral Microbiol. 2023;15(1):1. doi: 10.1080/20002297.2023.2186591
- Tarcoveanu E, Vasilescu A, Andronic D, et al. AbdominaL actinomycosis mimicking colon cancer. Chirurgia (Bucur). 2019;114(2):251–258. doi: 10.21614/chirurgia.114.2.251
- Peters BA, Dominianni C, Shapiro JA, et al. The gut microbiota in conventional and serrated precursors of colorectal cancer. Microbiome. 2016;4(1):69. doi: 10.1186/s40168-016-0218-6
- Segata N, Haake SK, Mannon P, et al. Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol. 2012;13(6):R42. doi: 10.1186/gb-2012-13-6-r42
- Bassis CM, Erb-Downward JR, Dickson RP, et al. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. MBio. 2015;6(2):e00037. doi: 10.1128/mBio.00037-15
- Flemer B, Warren RD, Barrett MPJ, et al. The oral microbiota in colorectal cancer is distinctive and predictive. BMJ Open Access. 2018;8(8):1454–1463. doi: 10.1136/GUTJNL-2017-3148
- Lu H, Ren Z, Li A, et al. Tongue coating microbiome data distinguish patients with pancreatic head cancer from healthy controls. J Oral Microbiol. 2019;11(1):1563409. doi: 10.1080/20002297.2018.1563409
- Shi YC, Cai S-T, Tian Y-P, et al. Effects of proton pump inhibitors on the gastrointestinal microbiota in gastroesophageal reflux disease. Int J Geno Prot. 2019;17(1):52–63. doi: 10.1016/j.gpb.2018.12.004
- Liao M, Xie Y, Mao Y, et al. Comparative analyses of fecal microbiota in Chinese isolated Yao population, minority Zhuang and rural han by 16sRNA sequencing. Sci Rep. 2018;8(1):1142. doi: 10.1038/s41598-017-17851-8
- Lee SH, Sung JY, Yong D, et al. Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions. Lung Cancer. 2016;102:89–95. doi: 10.1016/j.lungcan.2016.10.016
- Chen FG, Gao W, Yu C, et al. Age-associated changes of nasal bacterial microbiome in patients with chronic rhinosinusitis. Front Cell Infect Microbiol. 2022;12:786481. doi: 10.3389/fcimb.2022.786481
- Ma GQ, Zhang CH, Xu HB, et al. Analysis of human tongue microbial community structure by PCR-DGGE method. Jiang Xi Science. 2018;36:923–926. doi: 10.13990/j.issn1001-3679.2018.06.005
- Robinson AD, Eich ML, Varambally S. Dysregulation of de novo nucleotide biosynthetic pathway enzymes in cancer and targeting opportunities. Cancer Lett. 2020;470:134–140. doi: 10.1016/j.canlet.2019.11.013
- Vander HM, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–1033. doi: 10.1126/science.1160809